Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 19, 2017
Pharmacy Choice - Pharmaceutical News - Dr. Reddy's arm announces start of Phase II trials of cancer drug [India Infoline News Service] - September 19, 2017

Pharmacy News Article

 9/13/17 - Dr. Reddy's arm announces start of Phase II trials of cancer drug [India Infoline News Service]

Aurigene Discovery Technologies Ltd., a wholly owned subsidiary of Dr. Reddy's Laboratories and a specialised biotechnology company has announced plans to initiate a Phase II trials of its CA-170 program, a PDL1-VISTA inhibitor to be conducted at sites in India. Aurigene Discovery Technologies, a wholly-owned subsidiary of Dr. Reddy's Laboratories and a specialised biotechnology company has announced plans to initiate a Phase II trials of its CA-170 program, a PDL1-VISTA inhibitor to be conducted at sites in India.

The announcement was made following the presentation of preliminary data from the initial 34 patients with cancer treated in the dose escalation stage of phase 1 trial of CA-170 at the European Society for Medical Oncology 2017 Congress by Aurigene's collaborator and licensee of CA-170, Curis, a biotechnology company focused on the development and commercialisation of innovative and effective therapeutics for the treatment of cancer, said the company in a BSE filing on Tuesday.

Dr. Reddy's Laboratories was trading at Rs 2175.30 per share, up by Rs 10.50 or 0.49% in the pre-opening session on Wednesday, on the BSE.



(c) 2017India Infoline Ltd. All rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 19: ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Last Chance
Sep 20: What's New? New Treatments for Type 2 Diabetes
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415